医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.

广告
第一作者: Martin S,Taylor
第一单位: Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.
作者单位: Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts. [1] Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.;Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts. [2] Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York. [3] Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. [4] Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. [5] Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.;Healthcare Optics Research Laboratory, Canon U.S.A., Inc., Cambridge, Massachusetts. [6] Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.;Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.;Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts. [7] Laboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, New York. [8] Johns Hopkins University School of Medicine, Baltimore, Maryland. [9] Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. [10] Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. [11] Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts. [12] Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.;Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts. [13] Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. [14] University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. [15] Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. [16] Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. [17] Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington. [18] Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.;The David H. Koch Institute for Integrative Cancer Research at MIT, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. [19] Clinical and Translational Epidemiology Unit and Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. [20] MGH Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. [21] Department of Obstetrics and Gynecology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts. [22] Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York.;European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, the Netherlands. [23] Department of Pathology, Mass General Brigham and Harvard Medical School, Boston, Massachusetts.;Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. [24]
DOI 10.1158/2159-8290.CD-23-0313
PMID 37698949
发布时间 2024-09-04
提交
  • 浏览0
Cancer discovery

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷